三元生物(301206) - 2025 Q3 - 季度财报
2025-10-26 07:35
山东三元生物科技股份有限公司 2025 年第三季度报告 证券代码:301206 证券简称:三元生物 公告编号:2025-080 山东三元生物科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示: □是 否 一、主要财务数据 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 会计差错更正 | | | | | 本报告期 | | | | 年初至报告 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 本报告期 | 上年同期 | | 比上年同 | 年初至报 | 上年同期 | | 期末比上年 | | | | | ...
洪汇新材(002802) - 2025 Q3 - 季度财报
2025-10-26 07:35
Financial Performance - The company's revenue for Q3 2025 was ¥100,221,480.11, a decrease of 24.84% compared to the same period last year[4] - Net profit attributable to shareholders was ¥9,378,637.27, down 45.26% year-on-year[4] - The basic earnings per share decreased by 50.00% to ¥0.05[4] - Total operating revenue for Q3 2025 was CNY 296,929,204.45, a decrease of 13.4% from CNY 343,209,622.21 in the same period last year[21] - Net profit for Q3 2025 was CNY 30,724,360.88, representing a decline of 30.5% compared to CNY 44,198,134.25 in the previous year[22] - Earnings per share for Q3 2025 was CNY 0.17, down from CNY 0.25 in the same quarter last year[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥681,002,770.59, a decrease of 1.07% from the previous year[4] - The company's total assets decreased to CNY 681,002,770.59 from CNY 688,358,316.36, reflecting a reduction of 1.9%[19] - Total liabilities decreased to CNY 48,131,989.03, down 22.7% from CNY 62,325,459.74 year-over-year[19] - The company's cash and cash equivalents decreased from RMB 110,326,606.01 at the beginning of the period to RMB 98,735,174.70 at the end of the period[17] Cash Flow - Operating cash flow net amount increased by 250.08% to ¥79,232,497.63 year-to-date[11] - Net cash flow from operating activities was ¥79,232,497.63, significantly up from ¥22,632,622.61 in the prior period, marking a 250.5% increase[25] - Cash inflow from investment activities totaled ¥684,252,448.11, compared to ¥615,738,375.48 in the previous period, reflecting an increase of 11.1%[25] - Net cash flow from investment activities was negative at -¥66,332,692.61, a decrease of 308.98% year-on-year[11] - Total cash outflow from financing activities was ¥25,512,175.20, a reduction from ¥78,070,622.07 in the previous period, showing a decrease of 67.3%[25] Research and Development - Research and development expenses were ¥11,106,368.13, a reduction of 40.97% compared to the previous year[10] - Research and development expenses were CNY 11,106,368.13, a decrease of 41.1% from CNY 18,814,536.37 in the previous year[22] Share Repurchase - As of September 30, 2025, the company has repurchased a total of 570,600 shares, accounting for 0.31% of the total share capital, with a total payment of RMB 7,324,337[16] - The company plans to use its own funds to repurchase shares with a total amount not less than RMB 10 million and not exceeding RMB 20 million, at a price not exceeding RMB 15.90 per share[15] - The company has a plan to continue the share repurchase based on market conditions and funding arrangements[16] - The highest transaction price for repurchased shares was RMB 13.01 per share, while the lowest was RMB 12.50 per share[16] - The company has a total of 4,400,604 shares held in the repurchase special securities account, representing 2.41% of the total share capital[15] Other Financial Metrics - The weighted average return on equity was 1.48%, down 1.22% from the previous year[4] - The company received government subsidies amounting to ¥332,167.00 during the reporting period[5] - The company's trading financial assets increased from RMB 165,505,401.26 to RMB 260,491,722.23 during the same period[17] - Accounts receivable rose from RMB 66,278,790.81 to RMB 75,800,076.89, indicating an increase in sales or credit terms[17] - The company's financing receivables decreased significantly from RMB 50,393,785.24 to RMB 4,609,058.79, indicating a potential reduction in financing activities[17] - The company reported a decrease in accounts payable to CNY 10,609,155.09 from CNY 13,361,736.70, a decline of 20.5%[19] - Deferred income tax assets increased to CNY 576,552.41 from CNY 468,560.98, reflecting a growth of 23.1%[19] Inventory - Inventory increased to CNY 23,173,427.10, up from CNY 22,050,448.46, indicating a growth of 5.1%[19] Audit and Accounting Standards - The company has not undergone an audit for the third quarter financial report[27] - The new accounting standards will not be applicable for the current reporting period[26]
华测检测(300012) - 2025 Q3 - 季度财报
2025-10-26 07:35
2025 年第三季度报告 华测检测认证集团股份有限公司 2025 年第三季度报告 证券代码:300012 证券简称:华测检测 公告编号:2025-044 华测检测认证集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 华测检测认证集团股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 2 华测检测认证集团股份有限公司 2025 年第三季度报告 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | ...
恒达新材(301469) - 2025 Q3 - 季度财报
2025-10-26 07:35
浙江恒达新材料股份有限公司 2025 年第三季度报告 证券代码:301469 证券简称:恒达新材 公告编号:2025-060 浙江恒达新材料股份有限公司 2025 年第三季度报告 浙江恒达新材料股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入(元) | 275,691,405.91 | 15.01% | 7 ...
万顺新材(300057) - 2025 Q3 - 季度财报
2025-10-26 07:35
Financial Performance - The company's revenue for Q3 2025 was ¥1,397,293,230.51, a decrease of 20.27% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥34,016,285.10, representing a decline of 26.56% year-on-year[5]. - The company reported a basic earnings per share of -¥0.0381, a decrease of 29.13% compared to the previous year[5]. - The company reported a net loss of ¥85,961,965.66, representing a 111.16% increase in losses compared to the previous year[12]. - Operating profit decreased by 57.60% to ¥-84,834,915.67, primarily due to lower sales gross margin and increased asset impairment losses[12]. - The total profit loss amounted to ¥-87,186,457.44, reflecting a 68.28% increase in losses year-over-year[12]. - The company reported a net loss of ¥85,961,965.66 for the current period, compared to a net loss of ¥40,709,881.66 in the previous period, indicating an increase in losses of approximately 111.1%[30]. - Operating profit for the current period was ¥-84,834,915.67, a decline from ¥-53,830,859.61 in the previous period, reflecting a worsening performance[30]. - Basic and diluted earnings per share were both reported at ¥-0.0978, worsening from ¥-0.0398 in the previous period[31]. Cash Flow and Liquidity - The cash flow from operating activities for the year-to-date was ¥148,443,285.22, an increase of 139.72%[5]. - Cash flow from operating activities showed a significant improvement, with a net cash inflow of ¥148,443,285.22, compared to a net outflow of ¥-373,730,484.79 in the previous year, marking a 139.72% change[13]. - The cash and cash equivalents at the end of the period increased by 35.21% to ¥1,627,750,011.31, driven by improved cash flow from operations[13]. - The company's cash and cash equivalents increased to CNY 1,932,444,362.56 from CNY 1,668,672,645.13, reflecting a growth of 15.8%[25]. - Cash and cash equivalents at the end of the period totaled ¥1,627,750,011.31, an increase from ¥1,203,840,703.53 at the end of the previous period[33]. Assets and Liabilities - Total assets at the end of the reporting period were ¥10,583,294,821.40, reflecting a growth of 2.94% from the end of the previous year[5]. - The total liabilities decreased significantly, with contract liabilities down by 47.22% to ¥17,210,789.73, due to fewer advance payments received[10]. - The total assets of the company reached CNY 10,583,294,821.40, compared to CNY 10,280,997,998.15 at the beginning of the period, representing an increase of 2.9%[27]. - The total liabilities increased to CNY 5,392,457,731.55 from CNY 5,036,196,906.29, marking a rise of 7.1%[27]. - The company’s retained earnings decreased to CNY 611,861,406.18 from CNY 707,826,458.78, a decline of 13.5%[27]. Operational Highlights - In the first three quarters of 2025, the company achieved operating revenue of RMB 4.09 billion, a year-on-year decrease of 13.86%[20]. - The aluminum processing business sold 128,000 tons, a year-on-year increase of 4%, with aluminum foil sales of 51,000 tons from Jiangsu and 28,000 tons from Anhui[20]. - The company is advancing the construction of the 100,000-ton power and energy storage battery foil project, which will result in a total capacity of 255,000 tons of aluminum foil and 260,000 tons of aluminum plate and strip upon completion[20]. - The company has fulfilled 8.56% of the total expected supply volume under the cooperation framework agreement with downstream aluminum foil customers for the period 2023-2026[23]. Research and Development - The company filed 9 invention patents and 25 utility model patents in the first three quarters of 2025, bringing the total number of effective patents to 402[21]. - New products developed include high-stretch battery aluminum foil and high-dain battery aluminum foil, with the former already in mass supply[21]. - The company is focused on enhancing research and development in new materials to improve product competitiveness and production efficiency[21]. - The company incurred research and development expenses of ¥69,096,479.21, up from ¥64,257,211.93, indicating a focus on innovation[30]. Challenges and Market Conditions - The company is facing challenges due to domestic and international aluminum price inversions, declining processing fees, and increased asset impairment losses[20]. - The company experienced a 62.11% decrease in tax refunds received, totaling ¥44,562,036.05, due to the cancellation of export tax rebates for aluminum processing products[13]. - The company's interest income decreased by 42.76% to ¥13,129,520.17, primarily due to lower bank deposit interest[11]. - The company recorded a 118.76% increase in other income, amounting to ¥33,458,190.72, mainly from government subsidies related to normal operations[11].
泰林生物(300813) - 2025 Q3 - 季度财报
2025-10-26 07:35
Financial Performance - The company's operating revenue for Q3 2025 was ¥67,363,245.41, a decrease of 21.84% compared to the same period last year[5] - The net profit attributable to shareholders was ¥1,180,325.54, down 75.06% year-on-year, while the net profit after deducting non-recurring gains and losses was -¥155,169.53, a decrease of 103.36%[5] - The company's basic earnings per share for the period was ¥0.01, down 75.00% year-on-year, while diluted earnings per share were ¥0.00, a decrease of 100.00%[5] - Total operating revenue decreased to ¥213,188,852.61 from ¥242,467,278.88, representing a decline of approximately 12.06% year-over-year[17] - Total operating costs decreased to ¥201,314,970.50 from ¥236,221,850.45, a reduction of about 14.77% year-over-year[17] - Net profit increased to ¥14,523,036.61 from ¥10,599,894.14, marking a growth of approximately 37.25% year-over-year[18] - The total comprehensive income attributable to shareholders increased to ¥14,723,274.72 from ¥11,314,672.20, an increase of about 30.67% year-over-year[18] Cash Flow - The cash flow from operating activities showed a net inflow of ¥14,859,155.99, representing a significant increase of 171.73% compared to the previous year[5] - Operating cash inflow for the current period was 255,549,763.42 CNY, up from 233,795,795.59 CNY in the previous period, representing an increase of approximately 9.4%[19] - Net cash flow from operating activities improved to 14,859,155.99 CNY from a negative 20,714,994.54 CNY in the previous period[19] - Cash inflow from investment activities totaled 763,283,824.00 CNY, compared to 569,235,804.24 CNY in the previous period, marking an increase of approximately 34%[20] - Net cash flow from investment activities was 18,597,586.88 CNY, down from 28,422,441.32 CNY in the previous period[20] - Cash flow from financing activities resulted in a net outflow of 40,384,964.10 CNY, compared to a net inflow of 4,725,027.41 CNY in the previous period[20] - The company received 11,174,000.00 CNY from financing activities, down from 15,645,426.70 CNY in the previous period[20] - Total cash outflow for operating activities was 240,690,607.43 CNY, compared to 254,510,790.13 CNY in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥934,063,765.94, a decrease of 2.69% from the end of the previous year[5] - Total current assets decreased from 632,761,878.52 CNY to 545,192,536.68 CNY, a reduction of approximately 13.78%[15] - Cash and cash equivalents decreased from 264,872,528.62 CNY to 134,971,542.57 CNY, a decline of about 49.0%[15] - Accounts receivable increased from 43,546,552.81 CNY to 49,034,637.68 CNY, an increase of approximately 12.1%[15] - Inventory increased from 144,134,014.09 CNY to 153,639,950.20 CNY, an increase of about 6.0%[15] - Total liabilities increased to ¥143,919,186.72 from ¥139,178,386.25, an increase of approximately 5.30%[16] - The equity attributable to shareholders decreased to ¥790,144,579.22 from ¥820,050,345.31, a decrease of about 3.65%[17] Shareholder Information - Total number of common shareholders at the end of the reporting period is 9,437[11] - The largest shareholder, Ye Daling, holds 37.73% of shares, totaling 45,724,000 shares[11] - The second-largest shareholder, Ni Weiju, holds 15.18% of shares, totaling 18,402,400 shares[11] - The company has committed to a share transfer agreement with Ni Weiju, locking in 12.1 million shares for 12 months[12] Other Financial Metrics - The company reported a significant increase in intangible assets, which rose by 153.85% to ¥27,715,686.10, primarily due to land purchases[8] - The company experienced a 245.94% increase in credit impairment losses, amounting to -¥1,457,109.13, due to an increase in accounts receivable[9] - The company reported a financial expense of -¥5,896,688.66, compared to a financial expense of ¥3,361,208.48 in the previous period, reflecting a significant change in financial performance[18] - Research and development expenses remained stable at ¥49,120,227.85 compared to ¥49,454,422.64, indicating a slight decrease of 0.68%[18] - The deferred income tax liabilities decreased to ¥3,225,150.58 from ¥3,393,283.59, a reduction of approximately 4.95%[16] Audit Information - The company did not undergo an audit for the third quarter financial report[21]
三维化学(002469) - 2025 Q3 - 季度财报
2025-10-26 07:35
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 证券代码:002469 证券简称:三维化学 公告编号:2025-033 重要内容提示: 山东三维化学集团股份有限公司 2025 年第三季度报告 山东三维化学集团股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 增减 | | 上年同期增减 | | 营业收入(元) | 692,192,823.90 | 3.61% | 1,941,003,742.64 | 14.63% | | 归属于上市公司股东的 | 33,102,940.52 | -46.18% | 153,458,199.34 | 5.14% | | 净利润(元) | | | | | | 归属于上市公司股东的 扣除非经常性损益的净 | 33,063,438.79 | -45.92% | 152,743,477. ...
融捷健康(300247) - 2025 Q3 - 季度财报
2025-10-26 07:35
Revenue and Profit - Revenue for Q3 2025 reached ¥219,131,373.02, an increase of 53.87% year-over-year, and cumulative revenue for the year-to-date is ¥651,895,498.63, up 37.01%[5] - Net profit attributable to shareholders for Q3 2025 was ¥19,006,715.87, a significant increase of 144.92% compared to the same period last year, with year-to-date net profit at ¥66,530,456.08, up 82.59%[5] - Total operating revenue for the current period reached ¥651,895,498.63, a 37% increase from ¥475,799,143.25 in the previous period[30] - Net profit for the current period was ¥91,494,163.14, representing an 82.3% increase compared to ¥50,135,304.15 in the previous period[31] - The net profit attributable to shareholders of the parent company was ¥66,530,456.08, up 82.7% from ¥36,436,656.27[31] Earnings Per Share - The basic and diluted earnings per share for Q3 2025 were both ¥0.0236, reflecting a 143.30% increase year-over-year, with year-to-date earnings per share at ¥0.0827, up 82.56%[5] - Basic and diluted earnings per share increased to ¥0.0827 from ¥0.0453, reflecting a 82.7% growth[32] Assets and Liabilities - Total assets at the end of Q3 2025 amounted to ¥1,483,623,693.28, representing a 13.85% increase from the end of the previous year[5] - Total assets increased to ¥1,483,623,693.28 from ¥1,303,178,909.04, marking a growth of about 13.83%[27] - Total current assets reached ¥1,037,094,250.29, up from ¥947,370,678.98, representing an increase of approximately 9.46%[27] - The total non-current assets amounted to ¥446,529,442.99, up from ¥355,808,230.06, reflecting an increase of approximately 25.5%[27] - Total liabilities increased to ¥254,085,300.91 from ¥161,355,071.96, indicating a 57.3% rise[28] - The total liabilities include accounts payable of ¥62,784,606.03, which increased from ¥58,698,257.52, showing a rise of about 10.5%[27] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥42,264,663.01, a substantial increase of 172.92%[5] - The company reported a significant increase in cash inflow from operating activities, up ¥169,880,100, or 35.16% year-over-year[21] - Cash inflows from operating activities totaled ¥652,982,438.87, a significant rise from ¥483,102,291.60 in the previous period[33] - The net cash flow from operating activities was $42,264,663.01, an increase from $15,485,973.51 in the previous period, reflecting a significant improvement[34] - Cash inflow from investment activities totaled $587,218,940.13, compared to $510,618,352.37 in the prior period, indicating a growth of approximately 15%[34] Shareholder Information - Total number of common shareholders at the end of the reporting period is 29,269[23] - The largest shareholder, Rongjie Investment Holdings, holds 14.54% of shares, totaling 116,912,302 shares[23] Other Financial Metrics - The company has seen a 100% increase in lease liabilities due to new warehouse leases during the reporting period[17] - The company reported a decrease in employee compensation payable from ¥30,260,509.28 to ¥29,310,627.78, a decline of approximately 3.1%[27] - The company reported a decrease in other comprehensive income, with a net amount of -¥3,779,607.86 compared to -¥3,571,132.45 in the previous period[32] - Cash outflow from financing activities was $8,609,201.54, down from $9,826,483.54, representing a decrease of about 12.4%[34] - The net increase in cash and cash equivalents was $7,272,153.87, a significant drop from $88,453,916.30 in the previous period[34] Accounting Standards - The company will implement new accounting standards starting in 2025, but this does not apply to the current reporting period[35] - The company did not undergo an audit for the third quarter financial report[36]
万安科技(002590) - 2025 Q3 - 季度财报
2025-10-26 07:35
浙江万安科技股份有限公司 2025 年第三季度报告 证券代码:002590 证券简称:万安科技 公告编号:2025-076 浙江万安科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 浙江万安科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 同一控制下企业合并 | | | | 上年同期 | 本报告 期比上 | | | 年初至报 | 告期末比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 本报告期 | | | ...
先锋新材(300163) - 2025 Q3 - 季度财报
2025-10-26 07:35
宁波先锋新材料股份有限公司 2025 年第三季度报告 证券代码:300163 证券简称:先锋新材 公告编号:2025-056 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 宁波先锋新材料股份有限公司 2025 年第三季度报告 一、主要财务数据 宁波先锋新材料股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入(元) | 46,346,702.54 | -19. ...